Key result
The occurrence of ≥1 ST shifts during continuous 12-lead ECG monitoring was associated with a increased risk of 14-day and 30-day composite endpoints.
Why the study?
Does 24-hour continuous 12-lead ECG ST monitoring add prognostic information to the TIMI Risk Score for predicting adverse events in patients with non-ST-elevation acute coronary syndromes?
Cohort (n=567)
Does 24-hour continuous 12-lead ECG ST monitoring add prognostic information to the TIMI Risk Score for predicting adverse events in patients with non-ST-elevation acute coronary syndromes?
Continuous 12-lead ECG ST monitoring identifies transient ischemic events that provide additive prognostic value to the TIMI risk score in patients with non-ST-elevation acute coronary syndromes.
Answers are grounded in this paper and cite their sources.
May add prognostic value to TIMI score in NSTE-ACS; hypothesis-generating and requires prospective validation before practice change.
BACKGROUND: Continuous 12-lead electrocardiographic (ECG) ST monitoring and the Thrombolysis In Myocardial Infarction Risk Score (TIMI-RS), both have been shown to be useful for early risk stratification in patients with non-ST elevation acute coronary syndromes (NSTACS). HYPOTHESIS: Transient ST ischemic events, detected by continuous 12-lead ECG ST monitoring, early in the course of NSTACS, may add prognostic information to the TIMI-RS. METHODS: In all, 567 consecutive patients with a NSTACS underwent 24-h continuous 12-lead ECG ST monitoring. An ST ischemic event was defined as a transient ST shift in any lead of > or = 0.10 mV compared with the reference ECG, lasting for > or = 1 min. RESULTS: The incidence of the composite of death, nonfatal myocardial infarction (or reinfarction) and recurrent ischemia by Day 14 was 22.2%. By Day 30, the incidence of the composite of death and nonfatal myocardial infarction (or reinfarction) was 14.7%. There was a significantly increased risk of 14-day (p value for trend < 0.001) or 30-day (p value for trend <0.001) composite endpoint with increasing of TIMI-RS. Moreover, the occurrence of > or = 1 ST shifts during ST monitoring was associated with a significantly increased risk of 14- (p value < 0.001) or 30-day (p value < 0.001) composite endpoint, and this was true throughout the groups of TIMI-RS. CONCLUSIONS: The present study suggests that continuous 12-lead ECG ST monitoring, early in the course of NSTACS, may serve as an affordable tool to add prognostic information to the TIMI-RS.
No takes yet. Share an insight, caveat, or question.
Zairis et al. (2005) conducted a cohort in Non-ST-elevation acute coronary syndromes (NSTACS) (n=567). ≥1 transient ST shifts during continuous 12-lead ECG ST monitoring vs. No ST shifts was evaluated on Composite of death, nonfatal myocardial infarction (or reinfarction) and recurrent ischemia by Day 14 (p=< 0.001). The occurrence of ≥1 ST shifts during continuous 12-lead ECG monitoring was associated with a increased risk of 14-day and 30-day composite endpoints.
Synapse has enriched 10 related papers. Consider them for comparative context: